• Thu, March 14, 2024
Michael Petusky Maintained (ANIK) at Buy with Increased Target to $37 on, Mar 14th, 2024
Michael Petusky of Barrington Research, Maintained "Anika Therapeutics, Inc." (ANIK) at Buy with Increased Target from $29 to $37 on, Mar 14th, 2024.
Michael, nor any peers, have made any analyst calls on ANIK in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30